Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


HHS Flu Pandemic Preparedness Plan Nearing Publication; Vaccine Purchasing Arrangement Uncertain

This article was originally published in The Pink Sheet Daily

Executive Summary

The National Vaccine Program Office will begin to take comments on the plan following its release in the next two weeks. One issue is the right mix of public and private sector vaccine purchases.

You may also be interested in...

Flu Pandemic Plan: Financial Incentives To Increase Manufacturing Capacity

HHS plans to increase its demand for influenza vaccine to strengthen the vaccine delivery system and expand manufacturing capacity, a draft document states. Use of adjuvants could expand the vaccine supply, HHS suggests.

Barr’s Expanded Thalidomide ANDA Could Increase Likelihood Of A Marketed Generic

Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts